Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Metronidazole Topical Cream, 0.75% | Metronidazole

11:30 EDT 23rd July 2014 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.
IMAGE metronidazole-structural-formula-01.jpgIMAGE Metronidazole-Crm-75-01.jpgIMAGE Metronidazole-Crm-75-02.jpg

Manufacturer

Actavis Mid Atlantic LLC, Lincolnton, NC 28092

Active Ingredients

Source

Clinical Trials [74 Associated Clinical Trials listed on BioPortfolio]

Prevention of Persistence of Bacterial Vaginosis

This purpose of this study will be to conduct a double-blind, randomized, controlled clinical trial to determine the association between intravaginal high dose metronidazole (750mg), intra...

Response of Clostridium Difficile Infection to Metronidazole Therapy

In this record review study, our objective is to determine the rates of cure, failure and relapse following treatment of C. difficile colitis with metronidazole.

A Randomised Controlled Trial of the Use of Topical Metronidazole (10%) to Reduce Pain After Haemorrhoidectomy

The purpose of this study is to determine whether metronidazole 10% ointment , applied topically three times a day in and around the anus, on the reduction of pain following haemorrhoidect...

Pharmacokinetic Interaction Study Between Budesonide and Metronidazole in Healthy Volunteers

The primary objective of this study is to describe a possible effect of metronidazole on PK of budesonide in healthy volunteers.

Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment

What is the difference between the use of one drug (Oral Metronidazole) versus the use of this same drug combined with another drug (Rifampin) in treatment of bacteria and infection-associ...

PubMed Articles [86 Associated PubMed Articles listed on BioPortfolio]

Proteomic Analysis of a NAP1 Clostridium difficile Clinical Isolate Resistant to Metronidazole.

Clostridium difficile is an anaerobic, Gram-positive bacterium that has been implicated as the leading cause of antibiotic-associated diarrhea. Metronidazole is currently the first-line treatment for...

Subjective adverse reactions to metronidazole in patients with amebiasis.

Subjective adverse reactions to metronidazole were analyzed in 111 patients with amebiasis. Metronidazole was administered to 36 patients at a daily dose of 2,250mg and 75 patients at daily doses lowe...

Performance of microbial fuel cells on removal of metronidazole.

The microbial fuel cells (MFCs) are the focus of extensive investigation as one of the promising technologies for renewable energy generation and wastewater treatment. Two-chambered MFCs were designed...

Indirect electroreduction as pretreatment to enhance biodegradability of metronidazole.

The removal of metronidazole, a biorecalcitrant antibiotic, by coupling an electrochemical reduction with a biological treatment was examined. Electroreduction was performed in a home-made flow cell a...

The mutation of the rdxA gene in metronidazole-resistant Helicobacter pylori clinical isolates.

Antibiotic resistance is an increasing problem throughout the developed world, and knowledge about different resistance mechanisms is consequential for efficient treatment of bacterial infections. Alt...

Search BioPortfolio:
Advertisement

Drugs and Medication Quicklinks


Searches Linking to this Drug Record

Advertisement